HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Category: SARS-Cov2
Virology
-
Paxlovid: The Ultimate Antiviral Pill
Introduction Paxlovid, the pill that has become the go-to treatment for COVID-19 treatment, was granted full approval in May by the Food And Drug Administration (FDA) for the treatment of mild-to-moderate…
-
HERE’S WHAT WE KNOW ABOUT COVID-19 AND AUTOIMMUNITY
Before we get into understanding the possible links between autoimmunity and COVID-19, it is imperative that we understand what autoantibodies are and how they affect our body. These self-attacking antibodies…
-
ACTIVE COVID-19 CASES CROSS THE 2 LAKH MARK IN KERALA
With a daily count of over 30,000 cases for the fourth consecutive day, Kerala accounts for around 70% of he total COVID-19 cases in the country. Active cases are over 2 lakhs and…
-
Pfizer-BioNTech vaccine becomes the first vaccine to receive full FDA validation
The vaccine by Pfizer-BioNTech is the first vaccine that has been lincensed for COVID-19. The mRNA vaccine has shown to prevent 95 percent of COVID-19 during the clinical trials and can…
-
ZyCoV-D : FIRST VACCINE FOR CHILDREN IN INDIA
Zydus Cadila’s DNA based vaccine ZyCoV-D becomes the first vaccine to receive emergency use authorization for children above 12 years of age. The three-dose vaccine has an efficacy rate of…
-
LAMBDA : NEW VARIANT WITH 7 MUTATIONS
Lambda, a new coronavirus variant has been declared as a “variant of interest” by the World Health Organization (WHO). 31 countries including United States, United Kingdom, France, Italy, Germany and…
-
INDIA ADMINISTERED OVER 32 CRORE DOSES, OVERTAKES US
Health ministry on Monday informed that as many as 32.8 crore doses of Covid-19 vaccines have been administered since the start of the vaccination drive that began from January 16….
-
NINE EUROPEAN COUNTRIES APPROVE INDIAN VACCINE COVISHIELD FOR GREEN PASS
European countries including, Austria, Germany, Slovenia, Greece, Estonia, Iceland, Ireland and Spain, and Switzerland have approved the Covishield COVID-19 vaccine for ‘Green Pass’. This comes after India has asked the…
-
ZYDUS CADILA’S VACCINE TO BE JUST AS EFFECTIVE WITH A TWO- DOSE REGIMEN
Highlights: Fifth vaccine to be authorized in India. Now effective with two doses. Company to manufacture 120M doses a year. If approved, it could be World’s first plasmid DNA shot….
-
SII TO SUPPLY 20 CRORE COVAVAX DOSES BY DEC 2021
The Maryland based company, Novavax’s covid-19 vaccine candiate, named Covavax in India is all set to be launched in August-September this year in association with the Pune based Serum Institute…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila